Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied 26.1% over the past six months (as of Oct. 27, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 24.4%). Year to ...

After a strong biotech rebound, one fund quietly walked away from sector beta, and the timing says more than the trade itself ...

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

Cathie Wood made several trades across her ARK ETFs on Monday, December 22, according to daily trade filings. The moves ...

The biotech sector, represented by the iShares Biotechnology ETF, has experienced a notable rally in recent months. The key driver of the 40% over the past six months has been a notable uptick in M&A ...

Fidelity MSCI Health Care Index ETF offers long-term growth potential, leveraging demographic tailwinds and biotech ...

The AI trade has been wobbling quite a bit in recent weeks, to say the least. And while the popping of the AI bubble hasn’t ...

Learn what an exchange-traded fund (ETF) is, how it works, its key benefits, risks, and simple steps to start investing in ETFs with confidence for beginners.

While everyone's watching AI reshape chipmakers and tech sectors, the most profound transformation may be unfolding where no one’s looking: biotech. Artificial intelligence is quietly powering the ...